conv.

← The whole story
Health
FDA panel votes on Grail's Galleri multi-cancer blood test

Grail shares surge 33% on FDA meeting documents

2 Sep 21 1:58 PM · 2d ago · 5 articles · 2 sources · development 2 of 6

Grail's stock jumped after the FDA posted documents ahead of the advisory committee meeting that suggested the agency may take a favorable view of the Galleri test; the FDA is not bound by the panel's advice but often follows it.

Grail shares surge 33% on FDA meeting documents
STAT News

“The real reason some so-called experts oppose FDA approval is because it could lead to government and private insurance coverage.”

WSJ Editorial Board, Opinion board · rss ↗

Grail Inc. Maker of the Galleri multi-cancer blood testFDA Molecular and Clinical Genetics Panel Independent advisory panelVinay Prasad Former FDA biologics chiefWSJ Editorial Board Opinion commentator

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 7 pieces in one hour at Yesterday, 9 AM; 27 pieces over 3 days (18 articles · 9 posts) Sep 20, 4 PM — 1 piece · 1 article — Newswires 1Sep 20, 5 PM — quietSep 20, 6 PM — quietSep 20, 7 PM — quietSep 20, 8 PM — quietSep 20, 9 PM — quietSep 20, 10 PM — quietSep 20, 11 PM — quietSep 21, 12 AM — quietSep 21, 1 AM — quietSep 21, 2 AM — quietSep 21, 3 AM — quietSep 21, 4 AM — 1 piece · 1 article — Newswires 1Sep 21, 5 AM — quietSep 21, 6 AM — quietSep 21, 7 AM — quietSep 21, 8 AM — quietSep 21, 9 AM — quietSep 21, 10 AM — quietSep 21, 11 AM — quietSep 21, 12 PM — quietSep 21, 1 PM — 1 piece · 1 article — Newswires 1Sep 21, 2 PM — quietSep 21, 3 PM — quietSep 21, 4 PM — 3 pieces · 3 articles — Google News 3Sep 21, 5 PM — quietSep 21, 6 PM — quietSep 21, 7 PM — quietSep 21, 8 PM — quietSep 21, 9 PM — quietSep 21, 10 PM — quietSep 21, 11 PM — quietSep 22, 12 AM — quietSep 22, 1 AM — quietSep 22, 2 AM — quietSep 22, 3 AM — quietSep 22, 4 AM — quietSep 22, 5 AM — quietSep 22, 6 AM — quietSep 22, 7 AM — quietSep 22, 8 AM — quietSep 22, 9 AM — quietSep 22, 10 AM — quietSep 22, 11 AM — quietSep 22, 12 PM — quietSep 22, 1 PM — quietSep 22, 2 PM — quietSep 22, 3 PM — quietSep 22, 4 PM — quietSep 22, 5 PM — quietSep 22, 6 PM — quietSep 22, 7 PM — quietSep 22, 8 PM — quietSep 22, 9 PM — quietSep 22, 10 PM — quietSep 22, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — 3 pieces · 2 articles · 1 post — Newswires 2, Mastodon 1Yesterday, 6 AM — 3 pieces · 3 posts — Mastodon 3Yesterday, 7 AM — quietYesterday, 8 AM — 1 piece · 1 article — Newswires 1Yesterday, 9 AM — 7 pieces · 5 articles · 2 posts — Newswires 5, Mastodon 2Yesterday, 10 AM — quietYesterday, 11 AM — quietYesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — 2 pieces · 1 article · 1 post — Mastodon 1, Newswires 1Yesterday, 5 PM — 1 piece · 1 article — Newswires 1Yesterday, 6 PM — 3 pieces · 2 articles · 1 post — Google News 2, Mastodon 1Yesterday, 7 PM — 1 piece · 1 post — Mastodon 1Yesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quietToday, 12 AM — quiet 1234–6
1WSJ editorial board urges FDA to clear…2Grail shares surge 33% on FDA meeting…3FDA's outside expert panel meets to vote…4–6Molecular and Clinical Genetics Panel…
Sep 21Sep 22yesterdaynow · 1:01 AM ET

What was reported 1 claim about this development

  1. 4 outlets A Grail Cancer Test for the FDA

    first by Hindustan Times, 2d ago · also STAT, WSJ, Investor's Business Daily

    4 more headlines

All 6 developments of FDA panel votes on Grail's Galleri multi-cancer blood test →

NewswiresGoogle NewsMastodon